Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunovant (IMVT) Gains from Investment Securities (2019 - 2026)

Immunovant filings provide 6 years of Gains from Investment Securities readings, the most recent being $38000.0 for Q4 2025.

  • Quarterly Gains from Investment Securities rose 107.17% to $38000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Dec 2025, down 81.08% year-over-year, with the annual reading at $7.7 million for FY2025, N/A changed from the prior year.
  • Gains from Investment Securities hit $38000.0 in Q4 2025 for Immunovant, up from -$167000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $8.1 million in Q3 2024 and bottomed at -$571000.0 in Q2 2021.
  • Average Gains from Investment Securities over 4 years is $1.3 million, with a median of $127000.0 recorded in 2022.
  • Peak annual rise in Gains from Investment Securities hit 207.4% in 2021, while the deepest fall reached 182.04% in 2021.
  • Immunovant's Gains from Investment Securities stood at $740000.0 in 2021, then tumbled by 82.84% to $127000.0 in 2022, then crashed by 517.32% to -$530000.0 in 2024, then soared by 107.17% to $38000.0 in 2025.
  • Per Business Quant, the three most recent readings for IMVT's Gains from Investment Securities are $38000.0 (Q4 2025), -$167000.0 (Q3 2025), and $1.4 million (Q2 2025).